Market Access

Building a Smart Data Model

Last summer, we used the term "Smart Data" to explain the opportunity we see for applying technology and information to strategic drug development decisions. At that time, there was a lot of hype around Big Data, and we made the distinction that the value for biopharma was not just in having high volumes of a variety of data with a frequent velocity, but in being able to make sense of the data.